Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study

In the last decade, targeting the immune system became a promising therapy in advanced lung cancer stages. However, in a clinical follow-up, patient responses to immune checkpoint inhibitors widely differ. Peripheral blood is a minimally invasive source of potential biomarkers to explain these diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Marc A., Rozy, Adriana, Wrenger, Sabine, Christopoulos, Petros, Muley, Thomas, Thomas, Michael, Meister, Michael, Welte, Tobias, Chorostowska-Wynimko, Joanna, Janciauskiene, Sabina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841510/
https://www.ncbi.nlm.nih.gov/pubmed/35174082
http://dx.doi.org/10.3389/fonc.2022.772076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841510/
https://www.ncbi.nlm.nih.gov/pubmed/35174082
http://dx.doi.org/10.3389/fonc.2022.772076

Ejemplares similares